Skip to content

Surgical outcomes following breast reconstruction in patients with and without a history of chest radiotherapy for Hodgkin lymphoma: a multicenter, matched cohort study

Surgical outcomes following breast reconstruction in patients with and without a history of chest radiotherapy for Hodgkin lymphoma: a multicenter, matched cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028655
Enrollment
191
Registered
2022-07-15
Start date
2022-07-14
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Z42.1 C81

Interventions

Group 1: Breast reconstruction in Hodgkin lymphoma survivors who received chest radiotherapy Group 2: Breast reconstruction in matched controls without a history of Hodgkin lymphoma or chest radiother

Sponsors

Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Group 1: Breast reconstructions in Hodgkin survivors diagnosed with BC after previous chest radiotherapy for Hodgkin and who had undergone BR after therapeutic or prophylactic mastectomy. Group 2: Control breast reconstructions after therapeutic or prophylactic mastectomy in patients without a history of HL or chest radiotherapy were matched to patients in group 1 on age at mastectomy (±five years), date of BR (±five years), and type of BR (direct-to-implant; tissue expander/implant; autologous with implant; autologous only) and timing of BR (immediate or delayed).

Exclusion criteria

Exclusion criteria: Breasts which had received radiotherapy for BC before BR were excluded. Patients were excluded if their electronic health records had missing data regarding supradiaphragmatic radiotherapy.

Design outcomes

Primary

MeasureTime frame
complication-related breast reconstruction failure or conversion

Secondary

MeasureTime frame
complication-related re-operation, capsular contracture, major donor-site complications, and complication-related ICU admission

Countries

Netherlands

Contacts

Public ContactM.A.M. Mureau

Department of Plastic and Reconstructive Surgery, Erasmus MC Cancer Institute, University Medical Centre Rotterdam, Rotterdam, The Netherlands

m.mureau@erasmusmc.nl+31 10 704 01 37

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026